Pharma & Healthcare
Global Travelers Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 222859
- Pages: 76
- Figures: 78
- Views: 29
The global Travelers Vaccines market size was US$ 3976 million in 2024 and is forecast to a readjusted size of US$ 7118 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
The global Travelers Vaccines market is strategically segmented by company, region (country), by Type, and by End Users. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by End Users for 2020-2031.
Market Segmentation
By Company:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
By Type: (Dominant Segment vs High-Margin Innovation)
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Tourists
Students
Workers
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GlaxoSmithKline in Europe)
- Emerging Product Trends: Meningococcal Vaccine adoption vs. Japanese Encephalitis Vaccine premiumization
- Demand-Side Dynamics: Tourists growth in China vs. Students potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Travelers Vaccines market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Japanese Encephalitis Vaccine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Students in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Meningococcal Vaccine dominance in Europe vs. Japanese Encephalitis Vaccine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
The global Travelers Vaccines market is strategically segmented by company, region (country), by Type, and by End Users. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by End Users for 2020-2031.
Market Segmentation
By Company:
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
By Type: (Dominant Segment vs High-Margin Innovation)
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Tourists
Students
Workers
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., GlaxoSmithKline in Europe)
- Emerging Product Trends: Meningococcal Vaccine adoption vs. Japanese Encephalitis Vaccine premiumization
- Demand-Side Dynamics: Tourists growth in China vs. Students potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Travelers Vaccines market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Japanese Encephalitis Vaccine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Students in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Meningococcal Vaccine dominance in Europe vs. Japanese Encephalitis Vaccine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Travelers Vaccines Product Scope
1.2 Travelers Vaccines by Type
1.2.1 Global Travelers Vaccines Sales by Type (2020 & 2024 & 2031)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Travelers Vaccines by End Users
1.3.1 Global Travelers Vaccines Sales Comparison by End Users (2020 & 2024 & 2031)
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Global Travelers Vaccines Market Estimates and Forecasts (2020-2031)
1.4.1 Global Travelers Vaccines Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Travelers Vaccines Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Travelers Vaccines Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Travelers Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Travelers Vaccines Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Travelers Vaccines Sales Market Share by Region (2020-2025)
2.2.2 Global Travelers Vaccines Revenue Market Share by Region (2020-2025)
2.3 Global Travelers Vaccines Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Travelers Vaccines Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Travelers Vaccines Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Travelers Vaccines Market Size and Prospective (2020-2031)
2.4.2 Europe Travelers Vaccines Market Size and Prospective (2020-2031)
2.4.3 China Travelers Vaccines Market Size and Prospective (2020-2031)
2.4.4 Japan Travelers Vaccines Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Travelers Vaccines Historic Market Review by Type (2020-2025)
3.1.1 Global Travelers Vaccines Sales by Type (2020-2025)
3.1.2 Global Travelers Vaccines Revenue by Type (2020-2025)
3.1.3 Global Travelers Vaccines Price by Type (2020-2025)
3.2 Global Travelers Vaccines Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Travelers Vaccines Sales Forecast by Type (2026-2031)
3.2.2 Global Travelers Vaccines Revenue Forecast by Type (2026-2031)
3.2.3 Global Travelers Vaccines Price Forecast by Type (2026-2031)
3.3 Different Types Travelers Vaccines Representative Players
4 Global Market Size by End Users
4.1 Global Travelers Vaccines Historic Market Review by End Users (2020-2025)
4.1.1 Global Travelers Vaccines Sales by End Users (2020-2025)
4.1.2 Global Travelers Vaccines Revenue by End Users (2020-2025)
4.1.3 Global Travelers Vaccines Price by End Users (2020-2025)
4.2 Global Travelers Vaccines Market Estimates and Forecasts by End Users (2026-2031)
4.2.1 Global Travelers Vaccines Sales Forecast by End Users (2026-2031)
4.2.2 Global Travelers Vaccines Revenue Forecast by End Users (2026-2031)
4.2.3 Global Travelers Vaccines Price Forecast by End Users (2026-2031)
4.3 New Sources of Growth in Travelers Vaccines Application
5 Competition Landscape by Players
5.1 Global Travelers Vaccines Sales by Players (2020-2025)
5.2 Global Top Travelers Vaccines Players by Revenue (2020-2025)
5.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2024)
5.4 Global Travelers Vaccines Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Travelers Vaccines, Product Type & Application
5.7 Global Key Manufacturers of Travelers Vaccines, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Travelers Vaccines Sales by Company
6.1.1.1 North America Travelers Vaccines Sales by Company (2020-2025)
6.1.1.2 North America Travelers Vaccines Revenue by Company (2020-2025)
6.1.2 North America Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.1.3 North America Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.1.4 North America Travelers Vaccines Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Travelers Vaccines Sales by Company
6.2.1.1 Europe Travelers Vaccines Sales by Company (2020-2025)
6.2.1.2 Europe Travelers Vaccines Revenue by Company (2020-2025)
6.2.2 Europe Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.2.3 Europe Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.2.4 Europe Travelers Vaccines Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Travelers Vaccines Sales by Company
6.3.1.1 China Travelers Vaccines Sales by Company (2020-2025)
6.3.1.2 China Travelers Vaccines Revenue by Company (2020-2025)
6.3.2 China Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.3.3 China Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.3.4 China Travelers Vaccines Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Travelers Vaccines Sales by Company
6.4.1.1 Japan Travelers Vaccines Sales by Company (2020-2025)
6.4.1.2 Japan Travelers Vaccines Revenue by Company (2020-2025)
6.4.2 Japan Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.4.3 Japan Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.4.4 Japan Travelers Vaccines Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Information
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.1.4 GlaxoSmithKline Travelers Vaccines Products Offered
7.1.5 GlaxoSmithKline Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Information
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Sanofi Pasteur Travelers Vaccines Products Offered
7.2.5 Sanofi Pasteur Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Business Overview
7.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Merck Travelers Vaccines Products Offered
7.3.5 Merck Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Pfizer Travelers Vaccines Products Offered
7.4.5 Pfizer Recent Development
7.5 CNBG
7.5.1 CNBG Company Information
7.5.2 CNBG Business Overview
7.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.5.4 CNBG Travelers Vaccines Products Offered
7.5.5 CNBG Recent Development
7.6 Sanofi Pasteur MSD
7.6.1 Sanofi Pasteur MSD Company Information
7.6.2 Sanofi Pasteur MSD Business Overview
7.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Sanofi Pasteur MSD Travelers Vaccines Products Offered
7.6.5 Sanofi Pasteur MSD Recent Development
7.7 Serum Institute of India
7.7.1 Serum Institute of India Company Information
7.7.2 Serum Institute of India Business Overview
7.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Serum Institute of India Travelers Vaccines Products Offered
7.7.5 Serum Institute of India Recent Development
7.8 Biokangtai
7.8.1 Biokangtai Company Information
7.8.2 Biokangtai Business Overview
7.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Biokangtai Travelers Vaccines Products Offered
7.8.5 Biokangtai Recent Development
8 Travelers Vaccines Manufacturing Cost Analysis
8.1 Travelers Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Travelers Vaccines
8.4 Travelers Vaccines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Travelers Vaccines Distributors List
9.3 Travelers Vaccines Customers
10 Travelers Vaccines Market Dynamics
10.1 Travelers Vaccines Industry Trends
10.2 Travelers Vaccines Market Drivers
10.3 Travelers Vaccines Market Challenges
10.4 Travelers Vaccines Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Travelers Vaccines Product Scope
1.2 Travelers Vaccines by Type
1.2.1 Global Travelers Vaccines Sales by Type (2020 & 2024 & 2031)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Travelers Vaccines by End Users
1.3.1 Global Travelers Vaccines Sales Comparison by End Users (2020 & 2024 & 2031)
1.3.2 Tourists
1.3.3 Students
1.3.4 Workers
1.3.5 Others
1.4 Global Travelers Vaccines Market Estimates and Forecasts (2020-2031)
1.4.1 Global Travelers Vaccines Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Travelers Vaccines Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Travelers Vaccines Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Travelers Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Travelers Vaccines Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Travelers Vaccines Sales Market Share by Region (2020-2025)
2.2.2 Global Travelers Vaccines Revenue Market Share by Region (2020-2025)
2.3 Global Travelers Vaccines Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Travelers Vaccines Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Travelers Vaccines Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Travelers Vaccines Market Size and Prospective (2020-2031)
2.4.2 Europe Travelers Vaccines Market Size and Prospective (2020-2031)
2.4.3 China Travelers Vaccines Market Size and Prospective (2020-2031)
2.4.4 Japan Travelers Vaccines Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Travelers Vaccines Historic Market Review by Type (2020-2025)
3.1.1 Global Travelers Vaccines Sales by Type (2020-2025)
3.1.2 Global Travelers Vaccines Revenue by Type (2020-2025)
3.1.3 Global Travelers Vaccines Price by Type (2020-2025)
3.2 Global Travelers Vaccines Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Travelers Vaccines Sales Forecast by Type (2026-2031)
3.2.2 Global Travelers Vaccines Revenue Forecast by Type (2026-2031)
3.2.3 Global Travelers Vaccines Price Forecast by Type (2026-2031)
3.3 Different Types Travelers Vaccines Representative Players
4 Global Market Size by End Users
4.1 Global Travelers Vaccines Historic Market Review by End Users (2020-2025)
4.1.1 Global Travelers Vaccines Sales by End Users (2020-2025)
4.1.2 Global Travelers Vaccines Revenue by End Users (2020-2025)
4.1.3 Global Travelers Vaccines Price by End Users (2020-2025)
4.2 Global Travelers Vaccines Market Estimates and Forecasts by End Users (2026-2031)
4.2.1 Global Travelers Vaccines Sales Forecast by End Users (2026-2031)
4.2.2 Global Travelers Vaccines Revenue Forecast by End Users (2026-2031)
4.2.3 Global Travelers Vaccines Price Forecast by End Users (2026-2031)
4.3 New Sources of Growth in Travelers Vaccines Application
5 Competition Landscape by Players
5.1 Global Travelers Vaccines Sales by Players (2020-2025)
5.2 Global Top Travelers Vaccines Players by Revenue (2020-2025)
5.3 Global Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2024)
5.4 Global Travelers Vaccines Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Travelers Vaccines, Product Type & Application
5.7 Global Key Manufacturers of Travelers Vaccines, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Travelers Vaccines Sales by Company
6.1.1.1 North America Travelers Vaccines Sales by Company (2020-2025)
6.1.1.2 North America Travelers Vaccines Revenue by Company (2020-2025)
6.1.2 North America Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.1.3 North America Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.1.4 North America Travelers Vaccines Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Travelers Vaccines Sales by Company
6.2.1.1 Europe Travelers Vaccines Sales by Company (2020-2025)
6.2.1.2 Europe Travelers Vaccines Revenue by Company (2020-2025)
6.2.2 Europe Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.2.3 Europe Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.2.4 Europe Travelers Vaccines Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Travelers Vaccines Sales by Company
6.3.1.1 China Travelers Vaccines Sales by Company (2020-2025)
6.3.1.2 China Travelers Vaccines Revenue by Company (2020-2025)
6.3.2 China Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.3.3 China Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.3.4 China Travelers Vaccines Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Travelers Vaccines Sales by Company
6.4.1.1 Japan Travelers Vaccines Sales by Company (2020-2025)
6.4.1.2 Japan Travelers Vaccines Revenue by Company (2020-2025)
6.4.2 Japan Travelers Vaccines Sales Breakdown by Type (2020-2025)
6.4.3 Japan Travelers Vaccines Sales Breakdown by End Users (2020-2025)
6.4.4 Japan Travelers Vaccines Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Information
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.1.4 GlaxoSmithKline Travelers Vaccines Products Offered
7.1.5 GlaxoSmithKline Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Information
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Sanofi Pasteur Travelers Vaccines Products Offered
7.2.5 Sanofi Pasteur Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Business Overview
7.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Merck Travelers Vaccines Products Offered
7.3.5 Merck Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Pfizer Travelers Vaccines Products Offered
7.4.5 Pfizer Recent Development
7.5 CNBG
7.5.1 CNBG Company Information
7.5.2 CNBG Business Overview
7.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.5.4 CNBG Travelers Vaccines Products Offered
7.5.5 CNBG Recent Development
7.6 Sanofi Pasteur MSD
7.6.1 Sanofi Pasteur MSD Company Information
7.6.2 Sanofi Pasteur MSD Business Overview
7.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Sanofi Pasteur MSD Travelers Vaccines Products Offered
7.6.5 Sanofi Pasteur MSD Recent Development
7.7 Serum Institute of India
7.7.1 Serum Institute of India Company Information
7.7.2 Serum Institute of India Business Overview
7.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Serum Institute of India Travelers Vaccines Products Offered
7.7.5 Serum Institute of India Recent Development
7.8 Biokangtai
7.8.1 Biokangtai Company Information
7.8.2 Biokangtai Business Overview
7.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Biokangtai Travelers Vaccines Products Offered
7.8.5 Biokangtai Recent Development
8 Travelers Vaccines Manufacturing Cost Analysis
8.1 Travelers Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Travelers Vaccines
8.4 Travelers Vaccines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Travelers Vaccines Distributors List
9.3 Travelers Vaccines Customers
10 Travelers Vaccines Market Dynamics
10.1 Travelers Vaccines Industry Trends
10.2 Travelers Vaccines Market Drivers
10.3 Travelers Vaccines Market Challenges
10.4 Travelers Vaccines Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Travelers Vaccines Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Travelers Vaccines Sales (US$ Million) Comparison by End Users (2020 & 2024 & 2031)
Table 3. Global Market Travelers Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Travelers Vaccines Sales (K Doses) by Region (2020-2025)
Table 5. Global Travelers Vaccines Sales Market Share by Region (2020-2025)
Table 6. Global Travelers Vaccines Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Travelers Vaccines Revenue Share by Region (2020-2025)
Table 8. Global Travelers Vaccines Sales (K Doses) Forecast by Region (2026-2031)
Table 9. Global Travelers Vaccines Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Travelers Vaccines Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Travelers Vaccines Revenue Share Forecast by Region (2026-2031)
Table 12. Global Travelers Vaccines Sales by Type (K Doses) & (2020-2025)
Table 13. Global Travelers Vaccines Sales Share by Type (2020-2025)
Table 14. Global Travelers Vaccines Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Travelers Vaccines Price by Type (USD/Dose) & (2020-2025)
Table 16. Global Travelers Vaccines Sales by Type (K Doses) & (2026-2031)
Table 17. Global Travelers Vaccines Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Travelers Vaccines Price by Type (USD/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Travelers Vaccines Sales by End Users (K Doses) & (2020-2025)
Table 21. Global Travelers Vaccines Sales Share by End Users (2020-2025)
Table 22. Global Travelers Vaccines Revenue by End Users (US$ Million) & (2020-2025)
Table 23. Global Travelers Vaccines Price by End Users (USD/Dose) & (2020-2025)
Table 24. Global Travelers Vaccines Sales by End Users (K Doses) & (2026-2031)
Table 25. Global Travelers Vaccines Revenue Market Share by End Users (US$ Million) & (2026-2031)
Table 26. Global Travelers Vaccines Price by End Users (USD/Dose) & (2026-2031)
Table 27. New Sources of Growth in Travelers Vaccines Application
Table 28. Global Travelers Vaccines Sales by Company (K Doses) & (2020-2025)
Table 29. Global Travelers Vaccines Sales Share by Company (2020-2025)
Table 30. Global Travelers Vaccines Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Travelers Vaccines Revenue Share by Company (2020-2025)
Table 32. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2024)
Table 33. Global Market Travelers Vaccines Average Price by Company (USD/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Travelers Vaccines, Product Type & Application
Table 36. Global Key Manufacturers of Travelers Vaccines, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 39. North America Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 40. North America Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 42. North America Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 43. North America Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 44. North America Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 45. North America Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 46. Europe Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 47. Europe Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 48. Europe Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 50. Europe Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 51. Europe Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 52. Europe Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 53. Europe Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 54. China Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 55. China Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 56. China Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 58. China Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 59. China Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 60. China Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 61. China Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 62. Japan Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 63. Japan Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 64. Japan Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 66. Japan Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 67. Japan Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 68. Japan Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 69. Japan Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Travelers Vaccines Product
Table 74. GlaxoSmithKline Recent Development
Table 75. Sanofi Pasteur Company Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. Sanofi Pasteur Travelers Vaccines Product
Table 79. Sanofi Pasteur Recent Development
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Merck Travelers Vaccines Product
Table 84. Merck Recent Development
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Pfizer Travelers Vaccines Product
Table 89. Pfizer Recent Development
Table 90. CNBG Company Information
Table 91. CNBG Description and Business Overview
Table 92. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. CNBG Travelers Vaccines Product
Table 94. CNBG Recent Development
Table 95. Sanofi Pasteur MSD Company Information
Table 96. Sanofi Pasteur MSD Description and Business Overview
Table 97. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. Sanofi Pasteur MSD Travelers Vaccines Product
Table 99. Sanofi Pasteur MSD Recent Development
Table 100. Serum Institute of India Company Information
Table 101. Serum Institute of India Description and Business Overview
Table 102. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. Serum Institute of India Travelers Vaccines Product
Table 104. Serum Institute of India Recent Development
Table 105. Biokangtai Company Information
Table 106. Biokangtai Description and Business Overview
Table 107. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 108. Biokangtai Travelers Vaccines Product
Table 109. Biokangtai Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Travelers Vaccines Distributors List
Table 113. Travelers Vaccines Customers List
Table 114. Travelers Vaccines Market Trends
Table 115. Travelers Vaccines Market Drivers
Table 116. Travelers Vaccines Market Challenges
Table 117. Travelers Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Travelers Vaccines Product Picture
Figure 2. Global Travelers Vaccines Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Travelers Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. Meningococcal Vaccine Product Picture
Figure 5. Japanese Encephalitis Vaccine Product Picture
Figure 6. Yellow Fever Vaccine Product Picture
Figure 7. Hepatitis Vaccine Product Picture
Figure 8. Cholera Vaccine Product Picture
Figure 9. Other Product Picture
Figure 10. Global Travelers Vaccines Sales (US$ Million) by End Users (2020 & 2024 & 2031)
Figure 11. Global Travelers Vaccines Sales Market Share by End Users in 2024 & 2031
Figure 12. Tourists Examples
Figure 13. Students Examples
Figure 14. Workers Examples
Figure 15. Others Examples
Figure 16. Global Travelers Vaccines Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Travelers Vaccines Sales Growth Rate (2020-2031) & (US$ Million)
Figure 18. Global Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 19. Global Travelers Vaccines Price Trends Growth Rate (2020-2031) & (USD/Dose)
Figure 20. Travelers Vaccines Report Years Considered
Figure 21. Global Market Travelers Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 22. Global Travelers Vaccines Revenue Market Share by Region: 2020 VS 2024
Figure 23. North America Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. North America Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 25. Europe Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 27. China Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. China Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 29. Japan Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 31. Global Travelers Vaccines Revenue Share by Type (2020-2025)
Figure 32. Global Travelers Vaccines Sales Share by Type (2026-2031)
Figure 33. Global Travelers Vaccines Revenue Share by Type (2026-2031)
Figure 34. Global Travelers Vaccines Revenue Share by End Users (2020-2025)
Figure 35. Global Travelers Vaccines Revenue Growth Rate by End Users in 2020 & 2024
Figure 36. Global Travelers Vaccines Sales Share by End Users (2026-2031)
Figure 37. Global Travelers Vaccines Revenue Share by End Users (2026-2031)
Figure 38. Global Travelers Vaccines Sales Share by Company (2024)
Figure 39. Global Travelers Vaccines Revenue Share by Company (2024)
Figure 40. Global 5 Largest Travelers Vaccines Players Market Share by Revenue in Travelers Vaccines: 2020 & 2024
Figure 41. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 42. Manufacturing Cost Structure of Travelers Vaccines
Figure 43. Manufacturing Process Analysis of Travelers Vaccines
Figure 44. Travelers Vaccines Industrial Chain
Figure 45. Channels of Distribution (Direct Vs Distribution)
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Table 1. Global Travelers Vaccines Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Travelers Vaccines Sales (US$ Million) Comparison by End Users (2020 & 2024 & 2031)
Table 3. Global Market Travelers Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Travelers Vaccines Sales (K Doses) by Region (2020-2025)
Table 5. Global Travelers Vaccines Sales Market Share by Region (2020-2025)
Table 6. Global Travelers Vaccines Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Travelers Vaccines Revenue Share by Region (2020-2025)
Table 8. Global Travelers Vaccines Sales (K Doses) Forecast by Region (2026-2031)
Table 9. Global Travelers Vaccines Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Travelers Vaccines Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Travelers Vaccines Revenue Share Forecast by Region (2026-2031)
Table 12. Global Travelers Vaccines Sales by Type (K Doses) & (2020-2025)
Table 13. Global Travelers Vaccines Sales Share by Type (2020-2025)
Table 14. Global Travelers Vaccines Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Travelers Vaccines Price by Type (USD/Dose) & (2020-2025)
Table 16. Global Travelers Vaccines Sales by Type (K Doses) & (2026-2031)
Table 17. Global Travelers Vaccines Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Travelers Vaccines Price by Type (USD/Dose) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Travelers Vaccines Sales by End Users (K Doses) & (2020-2025)
Table 21. Global Travelers Vaccines Sales Share by End Users (2020-2025)
Table 22. Global Travelers Vaccines Revenue by End Users (US$ Million) & (2020-2025)
Table 23. Global Travelers Vaccines Price by End Users (USD/Dose) & (2020-2025)
Table 24. Global Travelers Vaccines Sales by End Users (K Doses) & (2026-2031)
Table 25. Global Travelers Vaccines Revenue Market Share by End Users (US$ Million) & (2026-2031)
Table 26. Global Travelers Vaccines Price by End Users (USD/Dose) & (2026-2031)
Table 27. New Sources of Growth in Travelers Vaccines Application
Table 28. Global Travelers Vaccines Sales by Company (K Doses) & (2020-2025)
Table 29. Global Travelers Vaccines Sales Share by Company (2020-2025)
Table 30. Global Travelers Vaccines Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Travelers Vaccines Revenue Share by Company (2020-2025)
Table 32. Global Travelers Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Travelers Vaccines as of 2024)
Table 33. Global Market Travelers Vaccines Average Price by Company (USD/Dose) & (2020-2025)
Table 34. Global Key Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Travelers Vaccines, Product Type & Application
Table 36. Global Key Manufacturers of Travelers Vaccines, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 39. North America Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 40. North America Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 42. North America Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 43. North America Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 44. North America Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 45. North America Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 46. Europe Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 47. Europe Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 48. Europe Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 50. Europe Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 51. Europe Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 52. Europe Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 53. Europe Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 54. China Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 55. China Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 56. China Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 58. China Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 59. China Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 60. China Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 61. China Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 62. Japan Travelers Vaccines Sales by Company (2020-2025) & (K Doses)
Table 63. Japan Travelers Vaccines Sales Market Share by Company (2020-2025)
Table 64. Japan Travelers Vaccines Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Travelers Vaccines Revenue Market Share by Company (2020-2025)
Table 66. Japan Travelers Vaccines Sales by Type (2020-2025) & (K Doses)
Table 67. Japan Travelers Vaccines Sales Market Share by Type (2020-2025)
Table 68. Japan Travelers Vaccines Sales by End Users (2020-2025) & (K Doses)
Table 69. Japan Travelers Vaccines Sales Market Share by End Users (2020-2025)
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Travelers Vaccines Product
Table 74. GlaxoSmithKline Recent Development
Table 75. Sanofi Pasteur Company Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. Sanofi Pasteur Travelers Vaccines Product
Table 79. Sanofi Pasteur Recent Development
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Merck Travelers Vaccines Product
Table 84. Merck Recent Development
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Pfizer Travelers Vaccines Product
Table 89. Pfizer Recent Development
Table 90. CNBG Company Information
Table 91. CNBG Description and Business Overview
Table 92. CNBG Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. CNBG Travelers Vaccines Product
Table 94. CNBG Recent Development
Table 95. Sanofi Pasteur MSD Company Information
Table 96. Sanofi Pasteur MSD Description and Business Overview
Table 97. Sanofi Pasteur MSD Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. Sanofi Pasteur MSD Travelers Vaccines Product
Table 99. Sanofi Pasteur MSD Recent Development
Table 100. Serum Institute of India Company Information
Table 101. Serum Institute of India Description and Business Overview
Table 102. Serum Institute of India Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. Serum Institute of India Travelers Vaccines Product
Table 104. Serum Institute of India Recent Development
Table 105. Biokangtai Company Information
Table 106. Biokangtai Description and Business Overview
Table 107. Biokangtai Travelers Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 108. Biokangtai Travelers Vaccines Product
Table 109. Biokangtai Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Travelers Vaccines Distributors List
Table 113. Travelers Vaccines Customers List
Table 114. Travelers Vaccines Market Trends
Table 115. Travelers Vaccines Market Drivers
Table 116. Travelers Vaccines Market Challenges
Table 117. Travelers Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Travelers Vaccines Product Picture
Figure 2. Global Travelers Vaccines Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Travelers Vaccines Sales Market Share by Type in 2024 & 2031
Figure 4. Meningococcal Vaccine Product Picture
Figure 5. Japanese Encephalitis Vaccine Product Picture
Figure 6. Yellow Fever Vaccine Product Picture
Figure 7. Hepatitis Vaccine Product Picture
Figure 8. Cholera Vaccine Product Picture
Figure 9. Other Product Picture
Figure 10. Global Travelers Vaccines Sales (US$ Million) by End Users (2020 & 2024 & 2031)
Figure 11. Global Travelers Vaccines Sales Market Share by End Users in 2024 & 2031
Figure 12. Tourists Examples
Figure 13. Students Examples
Figure 14. Workers Examples
Figure 15. Others Examples
Figure 16. Global Travelers Vaccines Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Travelers Vaccines Sales Growth Rate (2020-2031) & (US$ Million)
Figure 18. Global Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 19. Global Travelers Vaccines Price Trends Growth Rate (2020-2031) & (USD/Dose)
Figure 20. Travelers Vaccines Report Years Considered
Figure 21. Global Market Travelers Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 22. Global Travelers Vaccines Revenue Market Share by Region: 2020 VS 2024
Figure 23. North America Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. North America Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 25. Europe Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 27. China Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. China Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 29. Japan Travelers Vaccines Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Travelers Vaccines Sales (K Doses) Growth Rate (2020-2031)
Figure 31. Global Travelers Vaccines Revenue Share by Type (2020-2025)
Figure 32. Global Travelers Vaccines Sales Share by Type (2026-2031)
Figure 33. Global Travelers Vaccines Revenue Share by Type (2026-2031)
Figure 34. Global Travelers Vaccines Revenue Share by End Users (2020-2025)
Figure 35. Global Travelers Vaccines Revenue Growth Rate by End Users in 2020 & 2024
Figure 36. Global Travelers Vaccines Sales Share by End Users (2026-2031)
Figure 37. Global Travelers Vaccines Revenue Share by End Users (2026-2031)
Figure 38. Global Travelers Vaccines Sales Share by Company (2024)
Figure 39. Global Travelers Vaccines Revenue Share by Company (2024)
Figure 40. Global 5 Largest Travelers Vaccines Players Market Share by Revenue in Travelers Vaccines: 2020 & 2024
Figure 41. Travelers Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 42. Manufacturing Cost Structure of Travelers Vaccines
Figure 43. Manufacturing Process Analysis of Travelers Vaccines
Figure 44. Travelers Vaccines Industrial Chain
Figure 45. Channels of Distribution (Direct Vs Distribution)
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232